PODD CIK: 1145197

Insulet Corporation

  • United States
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
1.33
FY22:
1.31
FY23:
1.58
FY24:
1.89
FY25:
1.91
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.72
FY22:
0.94
FY23:
1.01
FY24:
1.20
FY25:
1.28
Total assets
Change from FY21 to FY25
billions USD
FY21:
2.05
FY22:
2.25
FY23:
2.59
FY24:
3.09
FY25:
3.19

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.23
FY22:
0.36
FY23:
0.45
FY24:
0.53
FY25:
0.68
(negative)
Change from FY21 to FY25
billions USD
FY21:
1.26
FY22:
1.41
FY23:
1.40
FY24:
1.35
FY25:
1.00
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.56
FY22:
0.48
FY23:
0.73
FY24:
1.21
FY25:
1.52
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
2.05
FY22:
2.25
FY23:
2.59
FY24:
3.09
FY25:
3.19

All amounts in billions USD Data source:SEC EDGAR